Association Between Three-Dimensional Transrectal Ultrasound Findings and Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: An Observational Study
Open Access
- 4 June 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11
Abstract
Background: There is a significant demand for the development of non-surgical methods for the evaluation of complete response to tumor therapy. Predicting ability and image quality of routine imaging has not been satisfactory. To avoid the deficiencies, we assessed the capability of three-dimensional transrectal ultrasound in predicting the response to neoadjuvant chemoradiotherapy in rectal cancer patients.Methods: The inclusion criteria were patients with locally advanced rectal adenocarcinoma, receiving capecitabine-based neoadjuvant chemoradiotherapy, distance from anal verge (≤6 cm), clinical stage T3-4 and/or N+ without evidence of distant metastasis, and restaging ycT0-3a (T3a PPPP=0.01) and regularity of the residual shape (OR=5.00, 95% CI=1.13–22.2, P=0.03) were kept in the final logistic model. The area under the curve of the logistic model was 0.84. Among these parameters, residual adjusted-thickness correlated significantly with tumor response. Additionally, we observed similar results in the whole population of 101 cases (whole dataset) and in the cross-validation.Conclusion: Three-dimensional transrectal ultrasound model is a valuable method for predicting tumor response in rectal cancer patients undergoing neoadjuvant chemoradiotherapy, which should be included as a factor for evaluating clinical complete response.Trial Registration: This trial was registered with ClinicalTrials.gov, number NCT02605265. Registered 9 November 2015 - Retrospectively registered, https://clinicaltrials.gov/ct2/show/record/NCT02605265Keywords
Funding Information
- Natural Science Foundation of Shanghai Municipality (19ZR1410600)
- Science and Technology Commission of Shanghai Municipality (19DZ2304900)
This publication has 27 references indexed in Scilit:
- Multicenter, Randomized, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by UGT1A1 Status in Patients With Locally Advanced Rectal CancerJournal of Clinical Oncology, 2020
- Non-Operative Management Versus Total Mesorectal Excision for Locally Advanced Rectal Cancer with Clinical Complete Response After Neoadjuvant Chemoradiotherapy: a GRADE Approach by the Rectal Cancer Guidelines Writing Group of the Italian Association of Medical Oncology (AIOM)Journal of Gastrointestinal Surgery, 2020
- An expansion study of genotype-driven weekly irinotecan and capecitabine in combination with neoadjuvant radiotherapy for locally advanced rectal cancer with UGT1A1 *1*1 genotypeTherapeutic Advances in Gastroenterology, 2019
- Endoscopic ultrasound measurements for detection of residual disease after neoadjuvant chemoradiotherapy for esophageal cancerEndoscopy, 2018
- Use of sequential endorectal US to predict the tumor response of preoperative chemoradiotherapy in rectal cancerGastrointestinal Endoscopy, 2017
- Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancerBritish Journal of Surgery, 2012
- The role of three-dimensional endoluminal ultrasound imaging in the evaluation of anorectal diseases: a reviewSurgical Endoscopy, 2008
- Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trialsBritish Journal of Radiology, 2005
- Comparative study of three-dimensional and conventional endorectal ultrasonography used in rectal cancer stagingSurgical Endoscopy, 2002
- Three-Dimensional Endosonography for Staging of Rectal CancerAnnals of Surgery, 1997